About Glaukos Corneal Health
Glaukos has acquired Avedro, Inc., for all future updates please follow @glaukos-corporation
http://investors.glaukos.com/investors/press-releases/press-release-details/2019/Glaukos-Completes-Acquisition-of-Avedro-Inc/default.aspx
We are focused on pioneering new treatments for chronic eye diseases. At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
|
|
|
1-10 employees
View all Glaukos Corneal Health employees
|
|
Pharmaceutical Manufacturing
|
|
(781) 768-3400
|
|
201 Jones Road, Waltham, MA 02451, US
|
|
Ophthalmics, Medical Device, Pharmaceuticals
|
Glaukos Corneal Health Alternatives
Glaukos Corneal Health Staff Directory
Search Glaukos Corneal Health Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
